Journal of Advanced Surgical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518-081136

Opinion Article - Journal of Advanced Surgical Research (2025) Volume 9, Issue 2

Precision surgical oncology: Tech, therapies, outcomes

Noor Al-Fahad*

Department of Oncologic Surgery, King Khalid University Hospital, Riyadh, Saudi Arabia

*Corresponding Author:
Noor Al-Fahad
Department of Oncologic Surgery
King Khalid University Hospital, Riyadh, Saudi Arabia.
E-mail: noor.alfahad@kkuh.sa

Received : 04-Apr-2025, Manuscript No. aaasr-207; Editor assigned : 08-Apr-2025, PreQC No. aaasr-207(PQ); Reviewed : 28-Apr-2025, QC No aaasr-207; Revised : 07-May-2025, Manuscript No. aaasr-207(R); Published : 16-May-2025 , DOI : 10.35841/2591-7765-9.2.207

Citation: Al-Fahad N. Precision surgical oncology: Tech, therapies, outcomes. aaasr. 2025;09(02):207.

Visit for more related articles at Journal of Advanced Surgical Research

Introduction

Surgical oncology continues to evolve rapidly, propelled by technological breakthroughs and innovative therapeutic strategies. The ultimate goal is always to improve patient outcomes while minimizing treatment burden. This field is increasingly characterized by a move towards more precise, less invasive, and highly individualized treatment approaches. Robot-assisted surgery is transforming colorectal cancer treatment, highlighting current practices and where this technology is headed. It emphasizes the substantial benefits and addresses the challenges associated with integrating robotics into modern surgical oncology for better patient outcomes [1].

In addition to advanced surgical techniques, significant strides are being made in perioperative immunotherapy for solid tumors. This review covers current applications and future possibilities, aiming to improve patient responses and overall survival rates by modulating the immune system around the time of surgery [2].

The overarching concept of precision surgery in oncology is providing a broad framework for cancer treatment. It details current methodologies and future prospects, underscoring how tailored approaches can substantially enhance surgical efficacy and patient care through individualized strategies [3].

Artificial Intelligence (AI) is also proving crucial in advancing surgical oncology. This technology is becoming indispensable for achieving more precise and effective cancer surgeries, fundamentally shaping the future direction of the field by offering unprecedented analytical and decision-making capabilities [4].

The ongoing evolution of minimally invasive surgical techniques has brought about a paradigm shift in cancer surgery. These advancements offer less invasive options, significantly improving patient recovery and reducing postoperative complications compared to traditional open procedures [5].

For specific and challenging diseases, such as gastric cancer, molecular targeted therapies are being explored in conjunction with surgical oncology. This approach outlines the current state and future potential of these targeted treatments, striving for better outcomes in a disease that often presents significant therapeutic hurdles [6].

Augmented Reality (AR) is another rapidly growing application in surgical oncology. This technology holds immense promise for enhancing surgical precision and guidance, with recent breakthroughs showing the potential to revolutionize how surgeons interact with patient anatomy during complex procedures [7].

The established importance of sentinel lymph node biopsy continues to be a cornerstone in surgical oncology. This technique plays a vital role in accurately staging cancer and guiding subsequent treatment decisions, thereby allowing for less extensive and often more targeted surgical interventions [8].

Recent progress in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for peritoneal surface malignancy represents a significant advancement. This specialized treatment, when combined with surgical resection, is demonstrably improving outcomes for patients with advanced cancers, offering a critical therapeutic option where few existed before [9].

Finally, the utility of liquid biopsy in surgical oncology is rapidly expanding. This non-invasive diagnostic tool assists in early detection, effective disease monitoring, and precise guidance for treatment decisions, showcasing substantial potential to transform patient management by offering real-time, less burdensome insights [10].

 

Conclusion

Surgical oncology is undergoing a transformative period, marked by the seamless integration of cutting-edge technologies and innovative therapeutic strategies, all geared towards significantly enhancing patient outcomes. Robot-assisted surgery, for example, is actively revolutionizing colorectal cancer treatment, leading to improved surgical precision and faster patient recovery. Complementing this, the widespread adoption of minimally invasive surgical techniques has become a cornerstone of modern practice, offering less aggressive interventions that translate to quicker recuperation times and reduced post-operative complications. The overarching philosophy of precision surgery further refines cancer care by tailoring approaches to individual patient characteristics and tumor biology, ensuring highly personalized and effective treatments. Beyond surgical advancements, novel therapeutic modalities are playing an increasingly crucial role. Perioperative immunotherapy for solid tumors, for instance, is making substantial strides in boosting patient responses and extending survival. For particularly challenging diseases such as gastric cancer, molecular targeted therapies are being strategically combined with surgical interventions to achieve more favorable results. Additionally, Hyperthermic Intraperitoneal Chemotherapy (HIPEC) shows significant promise for peritoneal surface malignancy, dramatically improving outcomes for patients with advanced cancers where traditional options are limited. Technological innovations continue to drive progress, with Artificial Intelligence (AI) advancing surgical precision and Augmented Reality (AR) enhancing intraoperative guidance, providing surgeons with unparalleled insights and control during complex procedures. Diagnostic and staging tools are also seeing continuous innovation; sentinel lymph node biopsy remains an essential technique for accurate staging and guiding treatment decisions, thereby preventing unnecessary extensive surgeries. Finally, liquid biopsy, a non-invasive and highly promising method, is rapidly gaining traction for its utility in early detection, continuous monitoring, and precise guidance for treatment decisions. These multifaceted, integrated approaches collectively underscore a comprehensive effort to make cancer surgery more effective, precise, and profoundly patient-friendly.

References

  1. Stefano G, Valeria D, Alessandro DG. Robot-assisted surgery in colorectal cancer: current trends and future directions.. Minerva Gastroenterol Dietol. 2022;68(4):307-313.

    2. Indexed at, Google Scholar, Crossref

  2. Yu S, Yizhi L, Meng H. Advances in perioperative immunotherapy for solid tumors: current status and future perspectives.. World J Surg Oncol. 2023;21(1):47.

    3. Indexed at, Google Scholar, Crossref

  3. Jia T, Siang THC, Thian KHL. Precision surgery in oncology: An overview of current approaches and future directions.. World J Gastrointest Surg. 2023;15(9):1668-1681.

    4. Indexed at, Google Scholar, Crossref

  4. Stephanie R, Aashish RS, Anisha K. Artificial intelligence in surgical oncology: The future of precision cancer surgery.. World J Gastrointest Surg. 2023;15(6):951-965.

    5. Indexed at, Google Scholar, Crossref

  5. Syed AS, Sandeep N, Vaibhav A. Evolution of minimally invasive surgery in oncology.. Indian J Surg. 2022;84(6):1549-1555.

    6. Indexed at, Google Scholar, Crossref

  6. Jing Y, Feng L, Zhen S. Molecular targeted therapy for surgical oncology of gastric cancer: current status and future perspectives.. Transl Cancer Res. 2021;10(7):3481-3490.

    7. Indexed at, Google Scholar, Crossref

  7. Carlotta P, Federico B, Giulia F. Augmented reality in surgical oncology: recent advances and future directions.. Minerva Med. 2023;114(6):687-695.

    8. Indexed at, Google Scholar, Crossref

  8. Veronika V, Miroslav R, Marketa V. Sentinel Lymph Node Biopsy in Surgical Oncology.. Acta Chir Hung. 2020;58(2-3):44-48.

    9. Indexed at, Google Scholar, Crossref

  9. Wei LYT, Thye CC, Wai LN. Recent advances in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancy.. J Clin Med. 2021;10(6):1251.

    10. Indexed at, Google Scholar, Crossref

  10. Nicola D, Roberto DG, Alessandra R. Liquid Biopsy in Surgical Oncology: A Systematic Review.. Cancers (Basel). 2022;14(18):4378.

    11. Indexed at, Google Scholar, Crossref

Get the App